Trials / Terminated
TerminatedNCT04267016
Acceptability and Feasibility of TruGraf® Testing as Part of the Standard of Care
A Clinical Pilot Study to Test the Acceptability and Feasibility of TruGraf® Testing as Part of the Standard of Care
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Transplant Genomics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is an observational study in renal transplant recipients to evaluate the acceptability, feasibility, and clinical utility of TruGraf® testing in conjunction with standard clinical assessment. TruGraf is the first and only non-invasive test approved by Medicare to rule out silent rejection in stable kidney transplant recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | TruGraf Testing - Peripheral blood gene expression profiling | 5 mL collection PAXgene blood sample |
Timeline
- Start date
- 2020-08-19
- Primary completion
- 2021-05-11
- Completion
- 2021-05-11
- First posted
- 2020-02-12
- Last updated
- 2021-09-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04267016. Inclusion in this directory is not an endorsement.